Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - AccuredShares IssuedShares OutstandingShares Outstanding
Ratios

Fulcrum Therapeutics (FULC) Shares Issued (2019 - 2026)

Fulcrum Therapeutics (FULC) has disclosed Shares Issued for 7 consecutive years, with $3.8 million as the latest value for Q4 2025.

  • Quarterly Shares Issued rose 4480.72% to $3.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.2 million through Dec 2025, up 51.75% year-over-year, with the annual reading at $4.2 million for FY2025, 51.75% up from the prior year.
  • Shares Issued for Q4 2025 was $3.8 million at Fulcrum Therapeutics, up from $64000.0 in the prior quarter.
  • The five-year high for Shares Issued was $3.8 million in Q4 2025, with the low at $47000.0 in Q1 2022.
  • Average Shares Issued over 5 years is $826500.0, with a median of $294000.0 recorded in 2023.
  • The sharpest move saw Shares Issued plummeted 96.08% in 2022, then surged 4480.72% in 2025.
  • Over 5 years, Shares Issued stood at $969000.0 in 2021, then tumbled by 72.45% to $267000.0 in 2022, then grew by 7.49% to $287000.0 in 2023, then tumbled by 71.08% to $83000.0 in 2024, then soared by 4480.72% to $3.8 million in 2025.
  • According to Business Quant data, Shares Issued over the past three periods came in at $3.8 million, $64000.0, and $301000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.